Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis.

about

Thrombospondin-1 regulation of latent TGF-β activation: A therapeutic target for fibrotic disease.Markers and Biomarkers of Endothelium: When Something Is Rotten in the State.

P2860

Q47243282-E5729C2A-27A9-4D2D-8B60-F6F53128504F Q48247130-AB879DF4-D000-42E5-8B1F-856F82F8D3F6

P2860

Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis.

Item

http://www.wikidata.org/entity/Q41980258

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Glycyrrhizin Ameliorates Fibro ...... Models of Systemic Sclerosis.

@en

type

Item

label

Glycyrrhizin Ameliorates Fibro ...... Models of Systemic Sclerosis.

@en

prefLabel

Glycyrrhizin Ameliorates Fibro ...... Models of Systemic Sclerosis.

@en

P1476

Glycyrrhizin Ameliorates Fibro ...... Models of Systemic Sclerosis.

@en

P2093

Ayumi Yoshizaki

http://www.w3.org/2001/XMLSchema#string

Kouki Nakamura

http://www.w3.org/2001/XMLSchema#string

Maria Trojanowska

http://www.w3.org/2001/XMLSchema#string

Ryosuke Saigusa

http://www.w3.org/2001/XMLSchema#string

Shinichi Sato

http://www.w3.org/2001/XMLSchema#string

Takashi Taniguchi

http://www.w3.org/2001/XMLSchema#string

Takashi Yamashita

http://www.w3.org/2001/XMLSchema#string

Takehiro Takahashi

http://www.w3.org/2001/XMLSchema#string

Tetsuo Toyama

http://www.w3.org/2001/XMLSchema#string

Yohei Ichimura

http://www.w3.org/2001/XMLSchema#string

P2860

Glycyrrhizic acid in the treatment of liver diseases: literature review

Latent TGF-β-binding proteins

Latent TGF-β structure and activation

Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy.

Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial.

Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver

Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats

Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis.

Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice

Effects of 18α-glycyrrhizin on TGF-β1/Smad signaling pathway in rats with carbon tetrachloride-induced liver fibrosis.

P304

631-640

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JID.2016.08.037

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

137

http://www.w3.org/2001/XMLSchema#string

P50

Shunsuke Miura

P577

2016-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27777101

http://www.w3.org/2001/XMLSchema#string

P932

5380226

http://www.w3.org/2001/XMLSchema#string

Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis.

about

P2860

P2860

Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932